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Purpose: Exertional heat stress adversely distrupts (GI) barrier integrity and, through 
subsequent microbial translocation (MT), negativly impacts health. Despite wide-
spread application, the temporal reliability of popular GI barrier integity and MT 
biomarkers is poorly characterised.
Method: Fourteen males completed two 80-min exertional heat stress tests (EHST) 
separated by 7–14  days. Venous blood was drawn pre, immediately- and 1-hr 
post both EHSTs. GI barrier integrity was assessed using the serum Dual-Sugar 
Absorption Test (DSAT), Intestinal Fatty-Acid-Binding Protein (I-FABP) and 
Claudin-3 (CLDN-3). MT was assessed using plasma Lipopolysaccharide Binding 
Protein (LBP), total 16S bacterial DNA and Bacteroides DNA.
Results: No GI barrier integrity or MT biomarker, except absolute Bacteroides 
DNA, displayed systematic trial order bias (p  ≥  .05). I-FABP (trial 1  =  Δ 
0.834 ± 0.445 ng ml−1; trial 2 = Δ 0.776 ± 0.489 ng ml−1) and CLDN-3 (trial 1 = Δ 
0.317 ± 0.586 ng ml−1; trial 2 = Δ 0.371 ± 0.508 ng ml−1) were increased post-
EHST (p  ≤  .01). All MT biomarkers  were unchanged post-EHST. Coefficient of 
variation and typical error of measurement post-EHST were: 11.5% and 0.004 (ratio) 
for the DSAT 90-min postprobe ingestion; 12.2% and 0.004 (ratio) at 150-min post-
probe ingestion; 12.1% and 0.376 ng ml−1 for I-FABP; 4.9% and 0.342 ng ml−1 for 
CLDN-3; 9.2% and 0.420 µg ml−1 for LBP; 9.5% and 0.15 pg µl−1 for total 16S DNA; 
and 54.7% and 0.032 for Bacteroides/total 16S DNA ratio.
Conclusion: Each GI barrier integrity and MT translocation biomarker, except 
Bacteroides/total 16S ratio, had acceptable reliability at rest and postexertional heat 
stress.
K E Y W O R D S
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1 |  INTRODUCTION
The gastrointestinal (GI) microbiota is a complex microbial 
ecosystem, which performs numerous functions symbiotic to 
human health (Cani, 2018). However, to prevent immune ac-
tivation, the microbiota must remain contained within the GI 
lumen, a process that is tightly regulated by the multilayered 
GI barrier (Wells et al., 2017). Exertional heat stress is one 
stimulus that adversely disrupts GI barrier integrity, and in 
a linear manner to the severity of splanchnic hypoperfusion 
(van Wijck et al., 2011) and core body temperature (Pires 
et al., 2017). In severe cases, luminal microbial products 
are capable of transversion into the systemic circulation, a 
response now considered to underlie multiple common ath-
letic health conditions (Costa, Snipe, Kitic, & Gibson, 2017). 
Specifically, the most concerning of these health conditions 
include exercise-induced anaphylaxis (Christensen et al., 
2019) and exertional heatstroke (Lim, 2018). In nonexercise 
settings, research has linked GI microbial translocation (MT) 
within the pathophysiology of numerous chronic diseases, in-
cluding GI disease (Camilleri, Madsen, Spiller, Meerveld, & 
Verne, 2012), cardiovascular disease (Neves, Coelho, Couto, 
Leite-Moreira, & Roncon-Albuquerque, 2013), and degen-
erative disorders of the central nervous system (Mulak & 
Bonaz, 2015). Thus, reliable biomarkers of GI barrier integ-
rity and/or MT appear important in the surveillance, diagno-
sis and treatment of these conditions. To date, there is little 
evidence documenting the reliability of most commonplace 
biomarkers, which limits interpretation of their application in 
both laboratory and field settings.
GI barrier integrity can be assessed in vivo using several 
biomarkers of intestinal permeability, epithelial injury, and 
tight junction integrity (Wells et al., 2017). The Dual-Sugar 
Absorption Test (DSAT) is the gold standard GI permeability 
biomarker (Bischoff et al., 2014). The traditional endpoint of 
the DSAT is the 5-hr urinary recovery of pre-ingested lact-
ulose-to-L-rhamnose (L/R; Bischoff et al., 2014) and offers 
good test–retest reliability when applied at rest (Marchbank 
et al., 2010). Analytical improvements have recently permit-
ted validation of a serum DSAT over a reduced (i.e., 1–3 hr) 
time course (van Wijck et al., 2013) and with improved di-
agnostic sensitivity (JanssenDuijghuijsen et al., 2016; Pugh 
et al., 2017). However, given the time course appearance of 
sugar probes within the blood (Fleming, Duncan, Russell, & 
Laker, 1996), potentially due to the wide heterogeneity in gas-
tric emptying rates following exercise (Costa et al., 2017), the 
reliability of this biomarker requires verification. Intestinal 
Fatty Acid-Binding Protein (I-FABP) is a cytosolic protein 
expressed exclusively within enterocytes of the duodenum/
jejunum, and has a half-life of 11 min in the systemic circu-
lation following epithelial injury (van de Poll et al., 2007). 
These characteristics have popularized I-FABP as a prom-
inent biomarker of small GI epithelial injury (Wells et al., 
2017), with serum concentrations strongly predictive of small 
GI histological injury (Schellekens et al., 2014). The tempo-
ral reliability of I-FABP has never been directly assessed and 
requires interrogation given its high sensitivity to subclinical 
small GI injury. Claudin-3 (CLDN-3) is a conserved GI ep-
ithelial transmembrane protein, which performs an integral 
role in GI paracellular homeostasis (Zeissig et al., 2007). As 
a biomarker of GI tight junction (TJ) integrity, preliminary 
research has shown a strong relationship between urinary 
CLDN-3 concentration and histological GI CLDN-3 break-
down (Thuijls, Derikx, Haan, et al., 2010a; Thuijls, Derikx, 
van Wijck, et al., 2010b). Similar to I-FABP, the temporal 
reliability of plasma CLDN-3 is currently unknown.
GI MT can be assessed in vivo through several indirect 
biomarkers considered to be indicative of systemic microbial 
exposure (Wells et al., 2017). Endotoxin, a form of lipopoly-
saccharide located on the outer membrane of gram-nega-
tive bacteria, has traditionally been utilized for this purpose 
(Costa et al., 2017). However, the search for improved GI MT 
biomarkers is ongoing, given endotoxin analysis is suscepti-
ble to both false-positive (e.g., from exogenous contamina-
tion) and false-negative (e.g., from rapid hepatic clearance) 
results (Dullah & Ongkudon, 2017). Lipopolysaccharide-
binding protein (LBP) is a type-1 acute phase protein, se-
creted hepatically following systemic exposure to numerous 
microbial-associated molecular patterns (Schumann, 2011). 
However, as an acute-phase protein, its temporal reliability 
is likely highly subject to influence from numerous co-vari-
ates (e.g. infection) (Citronberg et al., 2016). Bacterial DNA 
(bactDNA), through conserved 16S gene sequencing, is an 
emerging biomarker of GI MT (Paisse et al., 2016). In com-
parison with alternative MT measures, one major advantage 
of bactDNA is an apparent independence of hepatic clear-
ance (Mortensen et al., 2013). One innovative study recently 
proposed a bactDNA methodology aimed to improve analyt-
ical specificity and reliability through targeting a predom-
inant GI bacterial genus (Bacteroides) and correcting for 
total 16S DNA concentration (March, Jones, Thatcher, & 
Davison, 2019).
The aim of this study was to determine the reliability of 
biomarkers of GI barrier integrity (DSAT, I-FABP, CLDN-3) 
and microbial translocation (LBP, total 16s bacterial DNA, 
Bacteroides DNA) at rest and following exertional heat stress. 
These data should inform prospective research in this field, 
including biomarker selection and statistical power.
2 |  METHODS
2.1 | Participants and ethical approval
Fourteen healthy males (Table 1) volunteered to partici-
pate in the present study. All participants were nonsmokers, 
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habitually active, nonendurance trained (>4 hr week−1) and 
unacclimated to hot environments. A general medical ques-
tionnaire was used to screen for previous histories of gas-
trointestinal, cardiorespiratory, and metabolic illnesses. No 
participant took pharmacological medications (e.g., laxa-
tives, antibiotics) or reported suffering from an acute illness 
within 14 days prior to data collection. Informed consent was 
obtained for each participant following a full written and 
oral explanation of the experimental procedures. The study 
protocol was approved by Plymouth MARJON University 
Research Ethics Committee (Approval Code: EP040) and 
was conducted in accordance with the principles outlined 
in the Declaration of Helsinki, except for trial registration 
within a database.
2.2 | Experimental overview
Participants visited the laboratory on three occasions. During 
the first visit, baseline anthropometrics and maximal oxygen 
uptake (V̇O2max) were assessed. The second and third visits 
were the main experimental trials. These were separated by 
7–14  days to negate the influence of prior exertional heat 
stress on thermoregulatory (Barnett & Maughan, 1993) and 
GI barrier integrity (Snipe, Khoo, Kitic, Gibson, & Costa, 
2017) responses. During both main experimental trials, par-
ticipants completed an intermittent exertional heat stress test 
(EHST), consisting of two bouts of 40  min fixed-intensity 
treadmill walking (6  km  h−1 and 7% gradient) in the heat 
(35°C and 30% relative humidity; RH). The exercise bouts 
were separated by 20-min seated recovery  in the heat, in-
cluding 4-min forearm cold water immersion. This protocol 
is consistent with general military guidance on work/rest 
schedules for sustained physical activity in the heat (Military 
Headquarters of the Surgeon General, 2017) and unpub-
lished pilot data from our laboratory showing a ~2-fold el-
evation in DSAT responses relative to rest (n  =  6; DSAT 
90-min postprobe ingestion; [rest] = 0.014 ± 0.006, [post-
EHST] = 0.028 ± 0.005; p = .02). Data collection coincided 
with nonsummer months in Plymouth, United Kingdom, 
where daily mean ambient temperature at a local meteorolog-
ical station (Camborne, United Kingdom; latitude: 50.218°N) 
remained below 20°C (Met Office, 2019). A schematic illus-
tration of the protocol is shown in Figure 1.
2.3 | Dietary and lifestyle controls
Dietary supplementation (e.g., glutamine, probiotics, bo-
vine colostrum) and prolonged thermal exposures (e.g., 
saunas, sunbeds) were prohibited from 14 days before until 
the end of data collection (Costa et al., 2017). Alcohol, caf-
feine, strenuous physical activity and nonsteroidal anti-
inflammatory drugs (e.g., ibuprofen) were all abstained for 
48  hr before main experimental visits (Costa et al., 2017). 
Participants adhered to a ≥10 hr overnight fast and consumed 
500 ml of plain water 2 hr prior to main experimental visits. 




Body Mass (kg) 83.4 ± 12.6
Physical Activity (h·week−1) 6 ± 3
Body Fat (%) 16.1 ± 4.0
V̇O2max (ml·kg−1·min−1) 49 ± 4
F I G U R E  1  Schematic illustration of 
the experimental design and measurement 
timings
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Conformity with all pretrial controls was assessed in writing 
upon laboratory arrival using a pretrial control questionnaire. 
Participants were fasted throughout all main experimen-
tal trials (Edinburgh et al., 2018), but permitted 12 ml kg−1 
of ambient temperature water (28°C–30°C) to drink over 
the 20 min recovery following both 40-min EHST bouts.
2.4 | Anthropometric measurements
Participants height, weight, and body fat were measured fol-
lowing ISAK guidelines (Marfell-Jones, Olds, Stewart, & 
Carter, 2006). Height was measured barefoot using a sta-
diometer to the nearest 0.1  cm (Marsden HM-200), whilst 
body mass was measured on an electronic scale to the near-
est 0.05 kg (Tanita MC 180 MA). Skinfold thicknesses were 
taken in duplicate by the same researcher at the bicep, tricep, 
subscapular, and suprailliac using skinfold callipers to the 
nearest 0.1 cm (Harpenden, Holtain Ltd). Predictions of body 
density were calculated using age and gender-related equa-
tions (Durnin & Womersley, 1974).
2.5 | Maximal oxygen uptake
Maximal oxygen uptake (V̇O2max) was determined using an 
incremental treadmill test (Desmo HP, Woodway GmbH, 
Weil am Rhein, Germany) to volitional exhaustion. The 
test was undertaken in normothermic laboratory conditions 
(18°C–22°C, 40%–60% RH). The test began at a speed of 
10  km  h−1 on a fixed 1% inclination. The treadmill speed 
was then increased at 1 km h−1 increments every three min-
utes until reaching 13 km h−1, when inclination was then in-
creased by 2% every 2 min. Expired metabolic gases were 
measured continuously using a breath-by-breath metabolic 
cart (Metalyser 3B, Cortex). Heart rate (HR; Polar FT1, Polar 
Electro OY) and rating of perceived exertion (RPE; Borg, 
1970) were measuring during the final ten seconds of each 
stage. The highest 30 s average V̇O2 was taken to be V̇O2max.
2.6 | Exertional heat stress test
EHSTs commenced in the morning (08:30 ± 1 hr) to avoid 
the influence of circadian variation (Waterhouse et al., 
2005). Upon laboratory arrival, participants provided a capil-
lary blood sample into a K2EDTA microtube (Microvette®, 
Sarstedt) for duplicate hydration assessment via plasma os-
molality using freeze-point depression (Osmomat 3000, 
Gonotec). Participants then measured their own nude body 
mass (Tanita MC 180 MA). They then self-inserted a single 
use rectal thermistor (Tcore; Phillips 21090A) 12 cm beyond 
the anal sphincter and a HR monitor was positioned around 
their chest (EQ02, Equivital™). Participants then  dressed 
in standard summer military clothing (i.e., jacket [zipped, 
sleeves extended], trousers, boxer briefs, socks, trainers), 
and entered the environmental chamber that was regulated 
at  ~  35°C (Trial 1:  35.2  ±  0.3°C; Trial 2:  35.4  ±  0.4°C; 
p = .15) and ~ 30% RH (Trial 1: 28 ± 4%; Trial 2: 28 ± 2%; 
p =  .25). Skin thermistors (EUS-UU-VL3-O, Grant Instru-
ments) were then affixed on the participant using one layer 
(5 × 5 cm) of cotton tape (KT Tape®, KT Health) and mean 
skin temperature (Tskin) was calculated using standard equa-
tions (Ramanathan, 1964).
Participants then undertook the predefined EHST. 
Throughout, Tcore and Tskin were recorded using a temperature 
logger (Squirrel SQ2010, Grant Instruments) and HR using a 
Sensor Electronics Module (SEM) unit (EQ02, Equivital™). 
Mean whole body temperature (Tbody) was calculated from si-
multaneous Tcore and Tskin measurements (Jay & Kenny 2007). 
All data, including RPE (Borg et al., 1970) and thermal sensation 
(TS; Toner, Drolet, & Pandolf, 1986) were reported at 20-min 
intervals. Between the two walking bouts, participants immersed 
their forearms in a ~15°C cold water bath (Trial 1: 15.4 ± 0.8°C, 
Trial 2: 15.3 ± 0.7°C; p = .39). Upon EHST termination, partic-
ipants were removed from heat and their post-EHST nude body 
mass was recorded. Absolute sweat losses were calculated from 
the change in dry nude body mass from pre-to-post-EHST after 
correction for fluid intake and blood withdrawal.
2.7 | Blood collection and analysis
Venous blood samples (12  ml) were drawn immediately 
pre-, post- and 1-hr post-EHST. Participants stood upright 
for a minimum of 20 min before collection to allow capillary 
filtration pressure to stabilise (Shirreffs & Maughan, 1994). 
Blood was drawn from a forearm antecubital vein under min-
imal stasis (<30  s). Samples were collected proportionally 
into serum separator (SST II) and K2 EDTA tubes (Becton 
Dickinson and Company). The SST II tube was allowed to 
clot for 30–40 min at room temperature. A 0.5 ml aliquot of 
K2EDTA blood was removed for immediate hematological 
analysis. Samples were centrifuged at 1300 g for 15 min at 
4°C to separate serum and plasma. Aliquots were frozen at 
−80°C until analyses. All blood handling was performed with 
sterile (pyrogen, DNA, RNA free) pipette tips and microtubes.
2.8 | Hematology
Hemoglobin was measured in duplicate using a portable photomet-
ric analyser (Hemocue® Hb 201+, EFK Diagnostics; Duplicate) 
and hematocrit in duplicate using the microcapillary technique fol-
lowing centrifugation at 14,000 g for 4 min at room temperature 
(Haematospin 1400, Hawksley and Sons Ltd). Plasma volume 
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was estimated using standard equations (Dill & Costill, 1974). 
Postexercise analyte concentrations were left uncorrected for acute 
plasma volume shifts, given the similarity of responses between 
trials and the low molecular weights of quantified analytes.
2.9 | Dual-Sugar Absorption Test
Participants orally ingested a standard sugar probe solution 
containing 5 g Lactulose (Lactulose Oral Solution, Sandoz) 
and 2  g L-Rhamnose (L-rhamnose FG, 99% pure, Sigma 
Aldrich) dissolved within 50  ml of plain water (osmolal-
ity = ~750 mOsm·kg-1) 10 min into the EHST. Probe con-
centrations were determined from serum samples collected 
immediately pre, 90 min (i.e., post-EHST) and 150 min (i.e., 
1-hr post-EHST) post-probe ingestion following a previously 
described high performance liquid chromatography protocol 
(Fleming et al., 1996). The recovery of both sugars was de-
termined per litre serum (mg  L−1). Calculation of the L/R 
ratio was corrected relative (%) to the concentration of sugar 
consumed. The limit of detection was 0.1  mg  L−1 and the 
laboratory reference coefficient of variation was 1.8%–8.5% 
for both probes (Fleming et al., 1996).
2.10 | Enzyme linked immunosorbent assays
I-FABP ([1:2 serum dilution]; ELH-FABP2, Raybiotech®), 
CLDN-3 ([undiluted plasma]; EH1342, Wuhan Fine Biotech) 
and LBP ([1:250 plasma dilution]; RK01764, ABcloncal) 
were measured in duplicate immediately pre- and post-EHST 
using a solid-phase sandwich ELISA. Optical density was 
measured at 450 nm using a microplate reader and sample 
concentrations were determined from a logarithmic standard 
curve. The intra-assay coefficients of variation were 5.0% 
(I-FABP), 1.5% (CLDN-3), and 2.6% (LBP).
2.11 | Quantitative real-time polymerase 
chain reaction
BactDNA was measured in duplicate plasma samples col-
lected immediately  pre- and post-EHST using a quantita-
tive real-time polymerase chain reaction assay (qPCR) on a 
LightCycler 96 instrument (LightCycler 96, Roch). Cell-free 
DNA was isolated from plasma using a Quick-DNA Mini 
Prep Plus kit (D4068, Zymo Research) following manufactur-
er's instructions. Total 16S bacterial DNA was quantified ac-
cording to March et al. (2019) using a universal library probe 
(ULP, Roche, Basel, Switzerland), with standards (E2006-2, 
Zymo Research) and primers (Eurogentec, Liège, Belgium) 
specific to a 16S region (limit of detection 0.1  pg  µl−1). 
Bacteroides species DNA (Bact. DNA) were quantified using 
a double-dye probe/primer kit (Path-Bacteroides-spp, Genesig, 
Primerdesign Ltd). Negative controls (PCR grade water) for 
the entire extraction process were below the limit of detection 
for both measures. Ratio data are presented as Bacteroides/
total bacterial DNA (Bact./16S). The intra-assay coefficients 
of variation were 6.3% (total 16S) and 17.5% (Bacteroides).
2.12 | Statistics
All statistical analyses were performed using Prism Graphpad 
software (Prism V.8, La Jolla, California, USA). Comparisons 
were made after determining normal distribution using a 
Shapiro–Wilk test (p ≥ .05). A two-way analysis of variance 
(ANOVA) with repeated measures (time x trial) was used to 
identify differences between the two trials for whole-body 
physiological, GI barrier integrity, and MT data. If Mauchly's 
test for sphericity was violated, Greenhouse Geiser corrections 
were applied for epsilon <0.75, while the Huynh–Feldt correc-
tion was used for less severe asphericity. When there was only 
a single comparison, a paired t test or nonparametric Wilcoxon 
signed-ranks test was used to determine between-trial differ-
ences. Statistical significance was accepted at the alpha level of 
p ≤ .05. Data are presented as mean ± standard deviation (SD).
A composite a priori battery of statistical tests was con-
ducted to determine intertrial reliability (Atkinson & Nevill, 
1998). The DSAT was compared at each 90- and 150-min fol-
lowing sugar-probe ingestion, while each GI biomarker was 
compared at rest, post-EHST and the delta (Δ). Systematic bias 
was assessed using a paired t test or nonparametric Wilcoxon 
signed-ranks test. Meaningful differences were evaluated 
using Cohen's d (Lakens, 2013). Effect sizes were categorized 
as trivial (≤0.19), small (0.20–0.49), medium (0.50–0.79), 
and large (≥0.8). Relative reliability was assessed using a 
Pearson's product-moment correlation coefficient or nonpara-
metric Spearman's rank correlation coefficient. Correlations 
were classified as small (≤0.69), moderate (0.70–0.89) and 
high (≥0.90) (Vincent & Weir, 1995). Absolute reliability 
was assessed using each of the coefficient of variation ([SD/
mean]*100), typical error of the measurement (TEM; SD of 
difference between scores/√2) and Bland–Altman (B-A) plots 
with mean difference (bias), and 95% Limits of Agreement 
(LoA; Bland & Altman, 1986). CVs were classified as very 
good (≤10%) and acceptable (≤20%). Relationships between 
biomarkers were compared using a Pearson's product–moment 
correlation coefficient or nonparametric Spearman's rank cor-
relation coefficient. Heteroskedasticity was examined from 
the nonparametric correlational coefficient between absolute 
differences and individual means presented on B-A plots. 
Outliers were defined as ±2.4 SD units (normally distributed) 
or  ±4.0 SD units (nonnormally distributed) outside of the 
mean and were removed from subsequent analysis (Aguinis, 
Gottfredson, & Joo, 2013).
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2.13 | Power analysis
Given the novelty of the dependent variables being evaluated 
and statistical approach to undertake a battery of reliability 
statistical tests, it was determined infeasible to perform an a 
priori sample size calculation. Instead, general guidance on 
appropriate sample sizes (n = 12) for pilot studies were fol-
lowed, while accounting for a ~20% anticipated participant 
drop-out rate (Julious, 2005).
3 |  RESULTS
3.1 | Thermoregulatory, cardiovascular, and 
perceptual strain
Tcore (Figure 2a; time x trial p = .63), Tskin (Figure 2b; time 
x trial p = .13) and Tbody (Figure 2c; time × trial p = .43) 
all increased over time to a similar extent between trial 
one and two. The reliability of peak, mean, and Δ in Tcore, 
Tskin and Tbody were all good (Table 2). Pretrial plasma 
osmolality (trial one: 293  ±  7 mOsmol  kg−1, trial two: 
294 ± 7 mOsmol kg−1; p = .67), Δ plasma volume (trial 1: 
−0.61 ± 5.15%, trial 2: −0.02 ± 3.69%; p = .67), mean sweat 
rate (trial 1: 1.53 ± 0.38, trial 2:1.56 ± 0.45 L h−1; p = .61) 
and percentage body mass loss (trial 1: 1.15 ± 0.48; trial 2: 
1.21 ± 0.52%; p = .31) were all similar between trial one 
and two. HR (Figure 2d; time x trial p = .11), RPE (Figure 
2e; time x trial p  =  .38) and TS (Figure 2f; time  ×  trial 
p = .56) all increased over time to a similar extent between 
trial one and two. The reliability of peak, mean, and Δ HR, 
RPE, and TS were all good (Table 2).
3.2 | Dual-Sugar Absorption Test
Lactulose and L-rhamnose were both undetectable in all par-
ticipants’ basal sample prior to probe ingestion. Inter-trial 
DSAT responses displayed no systematic bias between tri-
als at both 90- (Figure 3a) and 150-min (Figure 3c). There 
was moderate relative reliability and acceptable absolute re-
liability at both the 90- and 150-min time-point. B–A plots 
F I G U R E  2  Whole-body physiological 
responses to repeated EHSTs: (a) = core 
temperature; (b) = mean skin temperature 
(n = 13); (c) = mean body temperature 
(n = 13); (d) = heart rate; (e) = thermal 
sensation; and (f) = rate of perceived 
exertion. Solid line = trial 1, broken 
line = trial 2. Significant overall effect of 
time (*p ≤ .05; **p ≤ .01)
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displayed bias for both the 90- (Figure 3b) and 150-min 
(Figure 3d) time-point. Individual Lactulose and L-rhamnose 
concentrations had worse reliability than the combined L/R 
ratio (Table 3). Heteroskedasticity was not present for any 
analyses.
3.3 | Intestinal fatty acid-binding protein
I-FABP displayed no trial order systematic bias at 
either rest, post- or the Δ time-point (Figure 3e). 
Following EHSTs, I-FABP was elevated above rest 
(trial 1: Δ  =  0.834  ±  0.445  ng·ml-1 [56  ±  31%]; trial 2: 
Δ = 0.776 ± 0.489 ng ml−1 [46 ± 26%]; p ≤  .01; Figure 
3e). At all-time-points, I-FABP displayed moderate rela-
tive and acceptable absolute reliability (Table 3). B–A 
plots are presented to illustrate bias for post-EHST concen-
trations (Figure 3f). Heteroskedasticity was not present for 
any analyses. One participant was excluded as an outlier. 
Two participants’ I-FABP responses displayed unexplaina-
bly poor reliability both at rest and post-EHSTs. These data 
were retained given where verbal adherence to pretrial con-
trols was verbally confirmed. However, removal of these 
data would have notably improved the reliability of I-FABP 
both at rest (r = 0.97; CV = 6.1%; TEM = 0.200 ng ml−1; 
B-A ± LoA = −0.046 ± 0.308 ng ml−1), and post-EHST 
(r = 0.97; CV = 7.2%; TEM = 0.221 ng ml−1; B-A ± LoA 
= 0.078 ± 0.467 ng ml−1).
3.4 | Claudin-3
CLDN-3 displayed no trial order systematic bias at either 
rest, post- or the Δ time-point (Figure 3g). Following EHSTs 
CLDN-3 was elevated above rest (trial 1: Δ  =  0.317  ±   
0.586 ng ml−1 [11 ± 17%]; trial 2: Δ = 0.371 ± 0.508 ng ml−1 
[9 ± 13%]; p ≤ .01; Figure 3g). At all time-points, CLDN-3 
displayed high relative and very good absolute reliability 
(Table 3). B-A plots are presented to illustrate bias for post-
EHST concentrations (Figure 3h). Heteroskedasticity was not 
present for any analyses.
3.5 | Lipopolysaccharide-binding protein
LBP displayed no trial order systematic bias at either rest, 
post-EHSTs or the Δ time-point (Figure 4a). There was no 
influence of the EHST on LBP concentration (p = .41). At 
all time-points, LBP displayed moderate relative and very 
good absolute reliability (Table 4). B-A plots are presented 
to illustrate bias for post EHST concentrations (Figure 4b). 
Heteroskedasticity was not present for any analyses.
T A B L E  2  Relative and absolute reliability of whole-body physiological responses
 
Trial 1
(SD) Trial 2 (SD) p d r CV TEM
Bias
(LoA)
Tcore (°C) Peak 38.63 ± 0.28 38.46 ± 0.37 .02 0.49 0.78** 0.5 0.14 0.17 ± 0.46
Tcore (°C) Mean 37.87 ± 0.19 37.78 ± 0.23 .09 0.43 0.68** 0.3 0.13 0.09 ± 0.43
Tcore (°C) Δ 1.62 ± 0.29 1.55 ± 0.44 .59 0.19 0.48 — 0.26 0.07 ± 0.77
Tskin (°C) Peak 36.27 ± 0.63 36.13 ± 0.65 .23 0.22 0.83** 0.6 0.27 0.13 ± 0.74
Tskin (°C) Mean 35.75 ± 0.44 35.64 ± 0.49 .13 0.24 0.83** 0.4 0.17 0.11 ± 0.46
Tskin (°C) Δ 1.65 ± 0.63 1.46 ± 0.65 .18 0.30 0.71** — 0.35 0.20 ± 0.97
Tbody (°C) Peak 38.54 ± 0.30 38.36 ± 0.37 .01 0.53 0.79** 0.4 0.16 0.18 ± 0.44
Tbody (°C) Mean 37.83 ± 0.20 37.74 ± 0.23 .08 0.42 0.70** 0.3 0.12 0.09 ± 0.33
Tbody (°C) Δ 1.62 ± 0.30 1.49 ± 0.40 .18 0.37 0.60* — 0.23 0.13 ± 0.63
HR (b·min−1) Peak 164 ± 13 162 ± 14 .19 0.15 0.93** 2.0 4 2 ± 11
HR (b·min−1) Mean 150 ± 14 148 ± 13 .29 0.14 0.84** 2.8 5 2 ± 15
HR (b·min−1) Δ 90 ± 11 90 ± 13 .99 0.00 0.88** — 4 0 ± 12
RPE (AU) Peak 16 ± 3 16 ± 3 .99 0.00 0.92** 4.1 1 0 ± 3
RPE (AU) Mean 13 ± 2 13 ± 2 .88 0.00 0.80** 5.2 1 0 ± 2
RPE (AU) Δ 6 ± 5 5 ± 3 .95 0.24 0.72** — 2 0 ± 4
TS (AU) Peak 7.0 ± 0.5 7.0 ± 0.5 .99 0.00 0.84** 4.8 0.5 0.0 ± 1.0
TS (AU) Mean 6.0 ± 0.5 5.5 ± 0.5 .02 0.00 0.88** 3.2 0.0 0.5 ± 0.5
TS (AU) Δ 2.5 ± 1.0 2.5 ± 0.5 .12 0.00 0.61* — 0.5 −0.5 ± 1.0
*Significant correlation (p ≤ .05); 
**Significant correlation (p ≤ .01). 
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F I G U R E  3  GI barrier integrity responses to EHST trial 1 and trial 2: (a) = L/R ratio at 90 min; (c) = L/R ratio at 150 min; (e) I-FABP 
(n = 13); and (g) = CLDN-3. Significant overall effect of time (*p ≤ .05; **p ≤ .01). Bland–Altman mean bias and 95% LoA between post-EHST 
trial 1 and trial 2: (b) = L/R ratio at 90- and (d) 150- min; (F) I-FABP (n = 13); and (h) = CLDN-3
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3.6 | Bacterial DNA
Total 16s (Figure 4c) and Bact./16S (Figure 4g) displayed 
no systematic bias at either rest, post EHSTs or the Δ. 
Bacteroides concentrations (Figure 4e) were systematically 
lower in trial 2 versus trial 1 (p = .04). At rest, total 16s dis-
played moderate relative and very good absolute reliability, 
whereas Bacteroides displayed poor relative and absolute re-
liability. The combined Bact./16S ratio subsequently showed 
poor relative and absolute reliability at rest (Table 4). There 
was no influence of the EHST on either total 16s (p = .39), 
Bacteroides (p = .33) or Bact./16S (p = .18) responses. B–A 
plots are presented to illustrate bias for post-EHST concentra-
tions (Figure 4d,f,h). Heteroskedasticity was not present for 
any analyses. One participant was excluded as an outlier.
3.7 | Association between biomarkers
Validation of the DSAT at the 90 and 150- min time-points 
across both trial one and trial two (n = 28), found responses 
to be systematically greater at 150- (0.034  ±  0.015) com-
pared with 90 min (0.027 ± 0.013; p = .05, ES 0.50). There 
was poor relative (r  =  0.08) and absolute (CV  =  31.8%, 
TEM  =  0.014) reliability between the  two DSAT sample 
points, suggestive of interindividual variability in sugar 
probe kinetics. Few statistically significant correlations 
were reported when comparing GI barrier integrity and 
MT biomarkers. Small positive correlations were reported 
between absolute post-EHST concentrations for I-FABP 
and CLDN-3 (r = 0.41, p =  .04), LBP and total 16s DNA 
(r = 0.48, p = .02), LBP and Bacteroides (r = 0.38; p = .05), 
Bacteroides, and total 16s DNA (r = 0.40, p = .04). When 
displayed as pre-to-post-DELTA, small positive correlations 
were reported between LBP and DSAT at 150 min (r = 0.54; 
p < .01).
4 |  DISCUSSION
The aim of this study was to determine the short-term 
(1–2 weeks) temporal reliability of several empirical biomark-
ers of GI barrier integrity (DSAT, I-FABP, CLDN-3) and MT 
(LBP, total 16s bacterial DNA, Bacteroides DNA) following 
exertional-heat stress. The main findings of this study were that 
the serum DSAT, I-FABP, CLDN-3, LBP and total 16s bacte-
rial DNA all displayed moderate-to-strong relative and accept-
able absolute reliability between repeat EHSTs. In comparison, 
absolute Bacteroides DNA and Bact./total 16s DNA ratio dis-
played weak relative and unacceptable absolute reliability be-
tween repeat EHSTs.
The serum DSAT is a valid alternative of the tra-
ditional urine DSAT (Fleming et al., 1996; van Wijck 
et al., 2011), whilst offering improved sensitivity to de-
tect transient losses in GI barrier integrity following exer-
cise (JanssenDuijghuijsen et al., 2016; Pugh et al., 2017). 
Despite this, the temporal reliability of the serum DSAT 
has never been previously assessed. Potential sources of 
variability with the serum DSAT might relate to both the 
transient time course of sugar probes in the blood and low 
absolute lactulose concentration that challenge the detec-
tion limit of common analytical techniques (Fleming et al., 
1996; van Wijck et al., 2013). In this study, we show for 
the first time that the serum DSAT can be utilized with 
T A B L E  3  Relative and absolute reliability of all GI barrier integrity biomarkers
 
Trial 1
(SD) Trial 2 (SD) p d r CV TEM
Bias
(LoA)
Lactulose (mg·L−1) 90 1.06 ± 0.38 0.90 ± 0.43 .33 0.38 0.60* 21.3 0.263 0.151 ± 0.730
L-Rhamnose (mg·L−1) 90 15.89 ± 3.91 15.85 ± 3.13 .29 0.29 0.53 12.9 2.601 1.036 ± 6.930
DSAT (L/R) 90 0.028 ± 0.012 0.025 ± 0.014 .17 0.23 0.77** 11.5 0.004 −0.003 ± 0.011
Lactulose (mg·L−1) 150 0.97 ± 0.48 0.95 ± 0.52 .53 0.05 0.71** 13.0 0.132 0.023 ± 0.364
L-Rhamnose (mg·L−1) 150 12.01 ± 2.95 11.24 ± 2.96 .09 0.27 0.86** 7.6 1.149 0.772 ± 3.060
DSAT (L/R) 150 0.033 ± 0.015 0.034 ± 0.016 .37 0.06 0.69** 12.2 0.004 0.001 ± 0.011
I-FABP (ng·ml−1) Rest 1.560 ± 0.506 1.691 ± 0.555 .11 0.25 0.75** 11.1 0.304 −0.180 ± 0.746
I-FABP (ng·ml−1) Post 2.394 ± 0.731 2.467 ± 0.875 .63 0.09 0.80** 12.1 0.376 −0.073 ± 1.040
I-FABP (ng·ml−1) Δ 0.834 ± 0.445 0.776 ± 0.489 .65 0.12 0.65** — 0.278 0.058 ± 0.772
CLDN−3 (ng·ml−1) Rest 6.205 ± 4.382 5.971 ± 4.062 .17 0.06 0.99** 6.8 0.423 0.233 ± 1.172
CLDN−3 (ng·ml−1) Post 6.592 ± 4.770 6.323 ± 4.270 .34 0.06 0.99** 4.9 0.485 0.181 ± 1.341
CLDN−3 (ng·ml−1) Δ 0.317 ± 0.586 0.371 ± 0.508 .68 0.10 0.62* — 0.342 −0.055 ± 0.948
*Significant correlation (p ≤ .05); 
**Significant correlation (p ≤ .01). 
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F I G U R E  4  GI MT responses to EHST trial 1 and trial 2: (a) = LBP; (c) total 16S bacterial DNA (n = 13); (e) = Bacteroides DNA; and 
(g) = Bacteroides/total 16s bacterial DNA (n = 13). Significant overall effect of trial (+p ≤ .05). Bland-Altman mean bias and 95% LoA between 
post-EHST trial 1 and trial 2: (b) = LBP; (d) = total 16S bacterial DNA (n = 13); (f) Bacteroides DNA (n = 13); and (h) = Bacteroides/total 16s 
bacterial DNA (n = 13)
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acceptable reliability, which is comparative to that previ-
ously reported with the urine DSAT when repeated over 
both a three-day (van Elburg et al., 1995) and two-week 
period (Marchbank et al., 2010). The optimal time-point 
for blood collection with the serum DSAT is an unresolved 
issue that concerns the methodological implementation 
of this measure. Herein, blood was collected at both 90-
min postprobe ingestion as this provides the most valid 
estimate of the urine DSAT in basal conditions (Fleming 
et al., 1996), and at 150-min post as this is where peak re-
sponses arose following similar exercise stress (van Wijck 
et al., 2011). Remarkedly, the temporal reliability of both 
time-points assessed was almost identical, though given 
large interindividual variation in probe kinetics, the mag-
nitude of responses at the two time-points had poor valid-
ity. Together, these findings advocate the use of the serum 
DSAT at either 90 or 150 min following probe ingestion 
(where logistically most convenient) as a reliable alterna-
tive to the urine DSAT.
I-FABP is the principal biomarker of GI epithelial in-
jury (Wells et al., 2017). Despite growing popularity, the 
temporal reliability of circulating I-FABP has never been 
previously assessed. In the present study, resting I-FABP 
concentrations were consistently at the  upper end of the 
general healthy reference range for studies utilizing a 
human ELISA kit (0.1–2.0  ng  ml−1; Treskes, Persoon, & 
Zanten, 2017). These concentrations must be considered 
when evaluating the absolute reliability thresholds reported 
herein. The rationale for large between-study discrepancies 
in absolute I-FABP concentrations are poorly understood, 
though are more likely attributable to analytical discrepan-
cies (e.g. ELISA antibody, ELISA wash procedure, sam-
ple storage), than participant demographic (Treskes et al., 
2017). The reliability of I-FABP at rest displayed moder-
ate relative and acceptable absolute reliability. Following 
both EHSTs, I-FABP increased by approximately 50% or 
0.800 ng ml−1. This response is comparable to numerous 
similar duration/intensity exercise protocols, such as: 45-
to-60  min of  ~70% wattmax normothermic cycling (van 
Wijck et al., 2011, [61%, Δ 0.306  ng  ml−1] 2012, [61%; 
Δ 0.179  ng  ml−1] and 20–30  min of  ~80% VO2max run-
ning (Barberio et al., 2015 [46%, Δ 0.297 ng ml−1]; March 
et al., 2017 [72%; Δ 0.350 ng ml−1]). In comparison, far 
greater elevations in I-FABP have been shown following 
90–120  min of moderate-intensity running performed in 
the heat (30°C; Morrison, Cheung, & Cotter, 2014 [663%; 
Δ 0.203–0.806  ng  ml−1]; Snipe et al., 2017 [288%, Δ 
0.897 ng ml−1]; 2018 [432%, Δ 1.230 ng ml−1]. Given the 
high sensitivity of I-FABP to even minor GI injury, it is 
vital that known extraneous variables (e.g., prandial/hydra-
tion status, prior exercise) are tightly controlled prior to 
investigation. Whilst participants in the present study pro-
vided written conformity to all pretrial controls, two partic-
ipants’ resting I-FABP concentrations appeared suspect to 
prior GI injury in one trial, which interestingly was unable 
to be detected by any other analyte.
CLDN-3 is the principle biomarker of GI TJ integrity 
(Wells et al., 2017). Despite introduction as a TJ biomarker 
almost a decade ago, the biological relevance of elevated cir-
culating CLDN-3 is still poorly understood. This includes 
the assessment of temporal reliability, which is currently un-
known. In the present study, resting CLDN-3 concentrations 
were consistent with previous evidence (0.5–15 ng ml−1) in 
healthy populations (Typpo et al., 2015; Yeh, Law, & Lim, 
2013). At rest, large interindividual variation in CLDN-3 
concentration was evident, meaning that relative reliability 
T A B L E  4  Relative and absolute reliability of all GI barrier integrity biomarkers
 
Trial 1
(SD) Trial 2 (SD) p d r CV TEM
Bias
(LoA)
LBP (µg·ml−1) Rest 2.625 ± 0.993 2.564 ± 0.871 .79 0.07 0.85** 10.0 0.378 0.061 ± 1.048
LBP (µg·ml−1) Post 2.617 ± 1.080 2.650 ± 0.885 .59 0.03 0.85** 9.2 0.420 −0.033 ± 1.166
LBP (µg·ml−1) Δ −0.008 ± 0.250 0.086 ± 0.232 .38 0.39 −0.16 — 0.260 −0.094 ± 0.721
16S DNA (pg·µl−1) Rest 1.43 ± 0.60 1.44 ± 0.65 .79 0.02 0.87** 8.1 0.19 −0.02 ± 0.49
16S DNA (pg·µl−1) Post 1.47 ± 0.70 1.52 ± 0.73 .45 0.07 0.82** 9.5 0.15 −0.05 ± 0.40
16S DNA (pg·µl−1) Δ 0.04 ± 0.28 0.08 ± 0.40 .72 0.10 0.56* — 0.24 −0.03 ± 0.65
Bact. DNA (copies·µl−1) Rest 0.142 ± 0.116 0.102 ± 0.089 .19 0.39 0.14 55.0 0.067 0.040 ± 0.186
Bact. DNA (copies·µl−1) Post 0.202 ± 0.132 0.115 ± 0.106 .04* 0.73 0.14 56.3 0.104 0.087 ± 0.287
Bact. DNA (copies·µl−1) Δ 0.059 ± 0.149 0.013 ± 0.140 .22 0.32 0.61* — 0.091 0.047 ± 0.250
Bact./16S DNA (x10−3) Rest 96.08 ± 59.31 74.10 ± 52.82 .31 0.39 0.13 60.2 52.49 −0.019 ± 0.348
Bact./16S DNA (x10−3) Post 143.41 ± 90.73 91.83 ± 124.76 .07 0.47 0.20 54.7 88.18 0.032 ± 0.347
Bact./16S DNA (x10−3) Δ 47.32 ± 95.74 17.74 ± 138.78 .35 0.25 0.69* — 76.88 0.052 ± 0.378
*Significant correlation (p ≤ .05); 
**Significant correlation (p ≤ .01). 
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was almost uniform. Following both EHSTs, plasma CLDN-3 
consistently increased by approximately 8%–10%. This find-
ing compares well to the only previous exercise study, where 
concentrations increased directly following a 1 hr moder-
ate-intensity (70% VO2max) run in both temperate (22°C; 
6.7 > 7.6 ng ml−1) and hot (33°C; 6.6 > 8.2 ng ml−1) ambi-
ent environments (Yeh et al., 2013). The clinical relevance of 
this small, transient increase in CLDN-3 following exercise 
is poorly understood, though it is modest in comparison with 
the magnitude of increase (4–20-fold) shown acutely follow-
ing major nonabdominal surgery (Habes et al., 2017; Typpo 
et al., 2015). Promisingly, of all the GI barrier integrity bio-
markers compared, CLDN-3 displayed the strongest relative 
and absolute reliability.
LBP is a type-1 acute phase protein that responds to a 
wide variety of microbial-associated molecular patterns and is 
widely considered a stable indirect biomarker of bacterial en-
dotoxin exposure (Dullah & Ongkudon, 2017). In the present 
study, resting LBP concentrations displayed showed moderate 
relative and good absolute reliability. These results are in sup-
port of one previous study, which found short-term (≤7 day) 
basal LBP responses to display moderate relative reliability 
(intraclass correlation coefficient  =  0.61; Citronberg et al., 
2016). In comparison, direct assessment of endotoxin appears 
to have weak basal temporal reliability, with an intraindivid-
ual CV of 22% reported over a similar 7-day period in basal 
conditions (Guy, Edwards, Miller, Deakin, & Pyne, 2017). 
Following the EHST, LBP was unchanged in both trials, with 
concentrations offering comparable levels of reliability com-
pared to rest. While the evidence is sparse regarding LBP 
responses to exercise, previous evidence has shown a minor 
elevation in LBP of 10%–15% immediately following a fatigu-
ing treadmill walk (4.5 km hr−1) in the heat (40°C; 106 min; 
Selkirk, McLellan, Wright, & Rhind, 2008), and 1 hr of mod-
erate intensity (70% VO2max) treadmill running (Jonvik et al., 
2019). A potential explanation for these discrepant findings 
likely relate to greater thermoregulatory/cardiovascular strain 
in previous studies.
BactDNA is an emerging GI MT biomarker, given the 
recent characterization of the blood microbiome and im-
provements in 16S PCR sensitivity (Paisse et al., 2016). In 
the present study, resting total 16S DNA concentrations 
displayed moderate relative and good absolute reliabil-
ity. This finding is promising, given previous  concerns 
that plasma bactDNA concentrations are susceptible  to 
contamination  during sample analysis (Glassing, Dowd, 
Galandiuk, Davis, & Chiodini, 2016). Quantification of 
total plasma 16S bacterial DNA in exercise settings has 
never been previously examined, though consistent with 
other MT biomarkers, the present results show total 16S 
bactDNA to be stable following moderate intensity ex-
ertional heat stress. One criticism of total 16S bactDNA 
assessment, particularly in exercise settings, is a lack of 
GI specificity, with total concentrations influenced by fac-
tors, including DNase concentration (Velders et al., 2014) 
and 16S DNA contamination from other body blood com-
partments (Paisse et al., 2016). To account for this error, 
one hypothetically improved method involves targeting a 
highly abundant GI genus such as Bacteroides (~30% of 
GI microbiota) and correcting for total 16S concentration 
(March et al., 2019). This method is particularly favor-
able given that the phyla Firmicutes and Bacteroidetes 
comprise  >90% of the GI microbiome (Bacteroides; 
Huttenhower et al., 2012) and <5% of the plasma microbi-
ome (Paisse et al., 2016). Utilizing this hypothesis, March 
et al. (2019) reported that the plasma Bacteroides/16S 
DNA ratio tended to increase (~25%; p =  .07) following 
a 1-hr moderate intensity (70% VO2max) run in the heat 
(30°C), though large interindividual variability in re-
sponses were evident. In this study, the Bacteroides/16S 
DNA ratio was unchanged following the EHST and ap-
peared to be systematically lower following exercise in 
trial two (but not the Δ). This systematic bias was unex-
pected given the uniformity of all other analytes assessed 
and the poor analytical reliability of this biomarker (e.g., 
mean duplicate CV  =  17.5%). It is presently unclear 
whether the poor reliability of this measure has obscured a 
true effect of the EHST and/or the meaningfulness of this 
variability during more severe MT.
Evidence directly comparing correlations between GI 
barrier integrity and/or MT biomarkers in exercise settings 
has been limited to date. Given general logistical constraints 
of the urine/serum DSAT, the majority of relevant evidence 
has attempted to validate (correlate) this method against 
more practical GI barrier integrity biomarkers. These stud-
ies generally report  significant, though weak correlations 
(r  =  0.4–0.6) between basal corrected (Δ) DSAT (urine 
5  hr) and I-FABP responses directly following moderate 
GI barrier integrity loss (March et al., 2017; van Wijck 
et al., 2011, 2012). In this study, the DSAT did not cor-
relate with any other GI integrity  biomarker. A potential 
explanation for this null finding might result from the lack 
of basal DSAT correction or the low overall severity of GI 
barrier integrity loss. In comparison, a small positive cor-
relation was reported between I-FABP and CLDN-3. This 
finding is supportive of previous evidence showing urinary 
I-FABP and CLDN-3 to weakly correlate (r  =  0.38) in 
patients with major nonabdominal surgery (Habes et al., 
2017). The expression of CLDN-3 across multiple tissues 
might partially explain why this correlation was not stron-
ger (Thuijls, Derikx, Haan, et al., 2010a). In general, no 
GI barrier integrity and MT biomarkers, except DSAT 150 
and Δ LBP, were found to correlate. Previous exercise gas-
troenterology research has shown various combinations 
of these biomarkers to correlate weakly (r = 0.1–0.6; Yeh 
et al., 2013; Sessions et al., 2016; March et al., 2019) or not 
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at all (Karhu et al., 2017; Snipe, Khoo, Kitic, Gibson, & 
Costa, 2018). Several physiological (e.g. hepatic/immune 
microbial clearance, transcellular microbial translocation, 
GI microbial density), and analytical (e.g., exogenous sam-
ple contamination, inconsistent biomarker kinetics, DSAT/
I-FABP limited to small GI integrity) factors all likely 
weaken these associations (Wells et al., 2017).
5 |  LIMITATIONS
Despite implementation of a tightly controlled methodolog-
ical design, which accounted for the majority of extraneous 
variables, the presented results are not without some limita-
tions. First, the EHST was only able to evoke moderate GI 
barrier integrity loss and did not influence MT, potentially 
limiting the application of these findings in severe situations 
of GI barrier integrity loss. A previous systematic review 
has suggested an exercise-induced hyperthermia threshold 
of 38.6°C Tcore for GI barrier integrity loss (DSAT, I-FABP 
and endotoxin) to be commonplace (>50% incidence) and 
of 39.0°C for GI barrier integrity loss to be universal (100% 
incidence;  Pires et al., 2017). Consistently, previous re-
search supports the notion that MT biomarkers (endotoxin) 
are less responsive to subtle alterations in GI barrier integ-
rity that were otherwise detected by the DSAT or I-FABP 
following exercise (March et al., 2019; Snipe et al., 2017, 
2018). Positively, no GI barrier integrity or MT biomarker 
displayed statistical heteroskedasticity in this EHST model, 
suggestive that absolute reliability was not dependent upon 
the magnitude of biomarker response. Next, biomarker 
analysis was limited to a single time-point after the EHST 
(at termination), though this can be justified in that peak 
responses are consistently shown to occur at this instance 
in comparable  exertional heat stress interventions (e.g., 
I-FABP, Snipe et al., 2017; CLDN-3, Yeh et al., 2013; LBP, 
Moncada-Jimenez et al., 2010; Bact./16S, March et al., 
2019). Third, there was statistically significant systematic 
bias for peak Tcore and Tbody responses, which were lower 
(0.17°C and 0.18°C) following implementation of trial two. 
This result was not anticipated, given numerous previous 
studies showing a one week washout period to be sufficient 
in preventing carry-over (heat acclimation) effects follow-
ing exertional heat stress exposure of comparable severity 
(Barrett and Maughan, 1993; Willmott et al., 2015). The 
meaningfulness of this systematic bias does not appear to 
statistically influence any GI barrier integrity of MT bio-
marker. Finally, neither a basal DSAT or urinary DSAT 
were performed, consequently preventing direct determina-
tion of the EHST on DSAT results or allowing comparisons 
between DSAT responses across biofluids. This decision 
was made to minimize participant time burden.
6 |  CONCLUSION
This is the first study to comprehensively assess the reliabil-
ity of GI barrier integrity and/or microbial translocation bio-
markers both at rest and following exertional (-heat) stress. 
Quantifying biomarker  reliability is a vital step required to 
inform marker selection for application in laboratory and 
field settings. Each of the GI barrier integrity biomarkers as-
sessed displayed moderate-to-good relative and accept-
able absolute reliability both at rest and post- EHST. Serum 
DSAT responses had comparable reliability at two separate 
time-points following sugar-probe ingestion (90- and 150-
min), though response kinetics displayed inconsistent time 
courses. I-FABP and CLDN-3 both increased following the 
EHST and their responses were found to weakly correlate. 
None of the selected microbial translocation biomakers were 
elevated following the EHST, suggestive that a greater sever-
ity of GI barrier integrity loss is required for MT. LBP and 
total 16S DNA both  demonstrated moderate-to-good rela-
tive and acceptable absolute reliability at both time-points. 
There was a weak correlation between LBP and total 16S 
post-EHST responses. Despite offering superior methodo-
logical rationale, Bacteroides DNA or Bacteroides/total 16S 
DNA had unacceptable reliability. The findings of the pre-
sent study have direct relevance for evaluating the efficacy 
of interventions to attenuate the rise in GI barrier integrity/
MT when exercising in the heat. Such interventions might 
include exercise training, heat acclimatization and nutritional 
supplementation. The findings of this study might also have 
value to the pharmaceutical industry, to quantify the efficacy 
of drugs to maintain GI barrier integrity, or to evaluate im-
provements in drugs that traditionally resulted in GI barrier 
integrity loss.
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